Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Interesting News About Bisphosphonate Zometa: Unlike Multiple Myeloma Related Studies, Zometa Found To Offer No Anti-Breast Cancer Protection

Home/Interesting News About Bisphosphonate Zometa: Unlike Multiple Myeloma Related Studies, Zometa Found To Offer No Anti-Breast Cancer Protection

Interesting News About Bisphosphonate Zometa: Unlike Multiple Myeloma Related Studies, Zometa Found To Offer No Anti-Breast Cancer Protection

I follow an underground, counter-culture type medical blog called Medicynic.  Always good to get a different perspective, right?  Here is a link to a story I read there today:  Why We Need Comparative Medical Studies:  Zometa.

The short post features several links back to reputable articles about how Zometa “did not appear to prevent breast cancer from returning or to boost disease-free survival overall.”

Why this is important for a bisphosphonate–I thought Zometa showing promise in slowing-down multiple myeloma was just a bonus–to extend disease-free survival.

But the story was important enough to be featured on WebMD and Bloomberg Business News. 

Tired of ASH news yet?  I hope not!  After giving you (and me!) a short break, I will be featuring a new ASH related article every day starting Monday for the next week or two.  I will also share a multi-part expose’ I am writing about the medical equipment industry.

Feel good and keep smiling!  Pat